Warning: The NCBI web site requires JavaScript to function. more...
Closed to reason: time for accountability for the International Narcotic Control Board.
Small D, Drucker E.
Harm Reduct J. 2007 May 8;4:13.
Related citations
Do international model drug control laws provide for drug availability?
University of Wisconsin Pain & Policy Studies Group.
J Pain Palliat Care Pharmacother. 2009;23(2):145-52.
Fighting addiction's death row: British Columbia Supreme Court Justice Ian Pitfield shows a measure of legal courage.
Small D.
Harm Reduct J. 2008 Oct 28;5:31.
Return to Galileo? The Inquisition of the International Narcotic Control Board.
Harm Reduct J. 2008 May 7;5:16.
Is there a gender gap in the HIV response? Evaluating national HIV responses from the United Nations General Assembly Special Session on HIV/AIDS country reports.
Carael M, Marais H, Polsky J, Mendoza A.
J Acquir Immune Defic Syndr. 2009 Dec;52 Suppl 2:S111-8.
Amazing grace: Vancouver's supervised injection facility granted six-month lease on life.
Harm Reduct J. 2008 Jan 24;5:3.
Insite: Canada's landmark safe injecting program at risk.
Drucker E.
Harm Reduct J. 2006 Aug 9;3:24.
Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE, Kleijnen J.
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29.
HIV, injecting drug use and harm reduction: a public health response.
Ball AL.
Addiction. 2007 May;102(5):684-90.
[Procedures and methods of benefit assessments for medicines in Germany].
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. Epub 2008 Nov 25. German.
Harm reduction headway and continuing resistance: insights from safe injection in the city of Vancouver.
Hathaway AD, Tousaw KI.
Int J Drug Policy. 2008 Feb;19(1):11-6.
Legislation analysis according to WHO and INCB criteria on opioid availability: a comparative study of 5 countries and the state of Texas.
Liliana De Lima MH, Sakowski JA, Stratton Hill C, Bruera E.
Health Policy. 2001 May;56(2):99-110.
Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy.
Elliott R, Csete J, Wood E, Kerr T.
Health Hum Rights. 2005;8(2):104-38. Review.
The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility.
Wood E, Kerr T, Tyndall MW, Montaner JS.
Int J Drug Policy. 2008 Jun;19(3):220-5.
Developing Canada's research base for harm reduction and health equity approaches to HIV prevention and treatment.
Shoveller J, DeBeck K, Montaner J.
Can J Public Health. 2010 Nov-Dec;101(6):442-4.
[1986-2006: 20 years of failed international policy to control AIDS in Africa].
Kerouedan D.
Med Trop (Mars). 2007 Oct;67(5):515-28. French.
Human rights in the global response to HIV: findings from the 2008 United Nations General Assembly Special Session Reports.
Gruskin S, Ferguson L, Peersman G, Rugg D.
J Acquir Immune Defic Syndr. 2009 Dec;52 Suppl 2:S104-10.
Family support for reducing morbidity and mortality in people with HIV/AIDS.
Mohanan P, Kamath A.
Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006046. Review.
KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies.
Bouchard RA.
Health Law J. 2007;15:247-94.
Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: what does the 2008 UNGASS reporting round tell us?
Mathers BM, Degenhardt L, Adam P, Toskin I, Nashkhoev M, Lyerla R, Rugg D.
J Acquir Immune Defic Syndr. 2009 Dec;52 Suppl 2:S132-42.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on